|
Quotes & Info
|
| VITA > SEC Filings for VITA > Form 8-K on 8-Jun-2009 | All Recent SEC Filings |
8-Jun-2009
Other Events, Financial Statements and Exhibits
On June 8, 2009, the U.S. Food and Drug Administration granted 510(k) clearance for Orthovita, Inc.'s CORTOSS™ Bone Augmentation Material in the treatment of vertebral compression fractures. The press release announcing the clearance is being furnished with this Current Report on Form 8-K as Exhibit 99.1 and is hereby incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press Release, dated June 8, 2009, issued by Orthovita, Inc.
|
|